{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:41:06Z","timestamp":1788172866950,"version":"build-2803163510"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,7,31]]},"DOI":"10.18632\/aging.204188","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T17:12:15Z","timestamp":1658596335000},"page":"5838-5854","source":"Crossref","is-referenced-by-count":10,"title":["Overexpression of 14-3-3\u03b6 primes disease recurrence, metastasis and resistance to chemotherapy by inducing epithelial-mesenchymal transition in NSCLC"],"prefix":"10.18632","volume":"14","author":[{"given":"Lingyun","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The First Medical Center of PLA General Hospital, Beijing 100853, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015.","volume":"6","author":"He","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.","volume":"36","author":"Yang","year":"2009","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.","volume":"30","author":"Fujii","year":"2004","journal-title":"Science"},{"key":"4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.","volume":"44","author":"Ishikawa","year":"2007","journal-title":"Nature"},{"key":"5","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer.","volume":"37","author":"Wilner","year":"2014","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.","volume":"37","author":"Hotta","year":"2016","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer.","volume":"37","author":"Felip","year":"2015","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","article-title":"First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.","volume":"37","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.","volume":"36","author":"Antonia","year":"2012","journal-title":"N Engl J Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.","volume":"37","author":"Arrieta","year":"2015","journal-title":"N Engl J Med"},{"key":"11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.","volume":"37","author":"Gainor","year":"2015","journal-title":"N Engl J Med"},{"key":"12","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.","volume":"38","author":"Sandler","year":"2020","journal-title":"N Engl J Med"},{"key":"13","first-page":"791","article-title":"Risk factors for recurrence in patients with resected N1 non-small cell lung cancer - a systematic review and meta-analysis.","volume":"2","author":"Zhang","year":"2015","journal-title":"J BUON"},{"key":"14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.","volume":"34","author":"Johnson","year":"2002","journal-title":"N Engl J Med"},{"key":"15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tcb.2008.10.003","article-title":"The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development.","volume":"1","author":"Morrison","year":"2009","journal-title":"Trends Cell Biol"},{"key":"16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0092-8674(00)81067-3","article-title":"Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine.","volume":"8","author":"Shaw","year":"1996","journal-title":"Cell"},{"key":"17","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cub.2004.07.051","article-title":"Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.","volume":"1","author":"Langeberg","year":"2004","journal-title":"Curr Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1517\/14728222.2012.668185","article-title":"14-3-3 zeta as novel molecular target for cancer therapy.","volume":"1","author":"Ralhan","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"19","first-page":"4353","article-title":"Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.","volume":"6","author":"Imai","year":"2000","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrc1230","article-title":"The 14-3-3 cancer connection.","volume":"3","author":"Hermeking","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1158\/0008-5472.CAN-08-2765","article-title":"14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.","volume":"6","author":"Yu","year":"2009","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1158\/1078-0432.CCR-08-0520","article-title":"Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer.","volume":"1","author":"Guo","year":"2008","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0070-2153(04)65008-3","article-title":"Differential functions of 14-3-3 isoforms in vertebrate development.","volume":"6","author":"Lau","year":"2005","journal-title":"Curr Top Dev Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s1097-2765(00)80002-7","article-title":"14-3-3sigma is a p53-regulated inhibitor of G2\/M progression.","volume":"1","author":"Vogelstein","year":"1997","journal-title":"Mol Cell"},{"key":"25","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1093\/carcin\/21.11.2073","article-title":"Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation.","volume":"2","author":"Hara","year":"2000","journal-title":"Carcinogenesis"},{"key":"26","doi-asserted-by":"publisher","first-page":"21639","DOI":"10.1074\/jbc.M203167200","article-title":"Identification of 14-3-3zeta as a protein kinase B\/Akt substrate.","volume":"27","author":"McLeish","year":"2002","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ccr.2009.08.010","article-title":"14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition.","volume":"1","author":"Muller","year":"2009","journal-title":"Cancer Cell"},{"key":"28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijc.20492","article-title":"Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues.","volume":"11","author":"Martinez","year":"2005","journal-title":"Int J Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition.","volume":"11","author":"Weinberg","year":"2009","journal-title":"J Clin Invest"},{"key":"30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition.","volume":"1","author":"Derynck","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/bcr2789","article-title":"Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.","volume":"1","author":"Mani","year":"2011","journal-title":"Breast Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10549-012-2390-0","article-title":"14-3-3\u03b6 as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers.","volume":"13","author":"Katzenellenbogen","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"33","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.7314\/apjcp.2014.15.8.3513","article-title":"Prognostic significance of 14-3-3\u03b3 overexpression in advanced non-small cell lung cancer.","volume":"1","author":"Thongsuksai","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"34","doi-asserted-by":"publisher","first-page":"7901","DOI":"10.1158\/0008-5472.CAN-07-0090","article-title":"Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.","volume":"6","author":"Jiang","year":"2007","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2011.01.015","article-title":"Silencing of 14-3-3\u03b6 over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium.","volume":"30","author":"Yoon","year":"2011","journal-title":"Cancer Lett"},{"key":"36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ijc.24346","article-title":"Copy number gain and oncogenic activity of YWHAZ\/14-3-3zeta in head and neck squamous cell carcinoma.","volume":"12","author":"Plass","year":"2009","journal-title":"Int J Cancer"},{"key":"37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.febslet.2004.05.068","article-title":"Identification of 14-3-3zeta as an EGF receptor interacting protein.","volume":"56","author":"Langdon","year":"2004","journal-title":"FEBS Lett"},{"key":"38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1128\/MCB.24.1.306-319.2004","article-title":"Snail mediates E-cadherin repression by the recruitment of the Sin3A\/histone deacetylase 1 (HDAC1)\/HDAC2 complex.","volume":"2","author":"Cano","year":"2004","journal-title":"Mol Cell Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1158\/0008-5472.CAN-10-0070","article-title":"14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation.","volume":"7","author":"Rauscher","year":"2010","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.","volume":"2","author":"Weinberg","year":"2019","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T18:22:26Z","timestamp":1659723746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,7,31]]}},"alternative-id":["204188","35876652"],"URL":"https:\/\/doi.org\/10.18632\/aging.204188","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}